PerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation (Nasdaq: VREX). PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that... Read more

BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering

Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively FRANKLIN LAKES, N.J., Apr. 27, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in... Read more

New data at AAN reinforce clinical benefit of Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Basel, 26 April 2017 New data at AAN reinforce clinical benefit of Roche’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis OCREVUS rapidly suppressed signs of disease activity in relapsing MS (RMS) patients In patients with early RMS – recently diagnosed and without prior treatment – OCREVUS was superior to Rebif® (interferon beta-1a) in... Read more

Two Pore Guys Raises $24.5 Million in Series A Financing

Investment Led by Khosla Ventures with Eye on Developing an Industry for Diagnostics Based on the 2PG Platform April 25, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), today announced the close of a Series A venture financing round in the amount of $24.5 million, led by Khosla Ventures.... Read more

Gyros Protein Technologies signs distribution agreement with Luxembourg Bio Technologies for peptide synthesis reagents

Agreement includes exclusive distribution of PurePep Coupling Agents in North America  Uppsala, Sweden, 25 April 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim®... Read more

United BioPharma selects GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals

CHALFONT ST. GILES, UK and HsinCHu, TAIWAN– 25 April 2017 – United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform to its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan. With this added capacity, UBP will support local healthcare needs by bringing... Read more

On-Demand Webinar: Quality with Confidence – What you need to know about digital microscopes for medical device quality processes

Digital microscopes – without eyepieces – are being used more frequently for quality inspection because of their ease of use, enhanced capabilities in 2D and 3D analysis, and reliable and repeatable results. This webinar from Leica will clear up common misconceptions about digital magnification, resolution and megapixels, and explain why optics in digital microscopes are... Read more